SCHEMBL2884550

SCHEMBL2884550

COC(=O)c1ccccc1CS(=O)(=O)Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
LMNA P02545 2/20 0.55
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA5A P35218 1/20 0.50
CA9 Q16790 1/20 0.50
TSHR P16473 1/20 0.49
HSD17B10 Q99714 2/20 0.47
CFTR P13569 1/20 0.47
HIF1A Q16665 1/20 0.47
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 2/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HTT P42858 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15461583 0.85 ALDH1A1 (0.57) ALDH1A1LMNACA1CA2CA5A
SCHEMBL7363401 0.85 ALDH1A1 (0.57) ALDH1A1LMNACA1CA2CA5A
SCHEMBL7948405 0.84 TSHR (0.61) ALDH1A1LMNATSHRHSD17B10KMT2A
SCHEMBL4880583 0.83 CA1 (0.58) ALDH1A1LMNACA1CA2CA5A
SCHEMBL646787 0.81 L3MBTL1 (0.54) ALDH1A1LMNACA1CA2CA5A
SCHEMBL4912518 0.81 ALDH1A1 (0.53) ALDH1A1LMNACA1CA2CA5A
SCHEMBL7946320 0.80 ALDH1A1 (0.44) ALDH1A1LMNATSHRHSD17B10HIF1A
SCHEMBL29539913 0.80 ALDH1A1 (0.51) ALDH1A1LMNACA1CA2CA5A
SCHEMBL9513083 0.80 ALDH1A1 (0.51) ALDH1A1LMNACA1CA2CA5A
SCHEMBL4784798 0.79 FOLH1 (0.52) ALDH1A1CA1CA2CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563236-A Synthesis method of o-methyl formate benzylsulfonamide 石家庄圣泰化工有限公司 2021-10-29 CN claimed
CN-113563236-A Synthesis method of o-methyl formate benzylsulfonamide 石家庄圣泰化工有限公司 2021-10-29 CN disclosed
US-8283373-B2 Inhibitors of cytosolic phospholipase A2 PFIZER INC. (US) 2012-10-09 US disclosed
CN-102040550-A Inhibitors of cytosolic phospholipase A2 WYETH CORP 2011-05-04 CN disclosed
CN-101184729-B Cytosolic phospholipase A2Inhibitors WYETH CORP 2011-02-16 CN disclosed
EP-1891006-B1 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 WYETH LLC (US) 2010-11-24 EP disclosed
EP-2248801-A1 Inhibitors of cytosolic phospholipase a2 Wyeth LLC (US) 2010-11-10 EP disclosed
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 WYETH LLC 2010-02-04 US disclosed
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 NOVARTIS AG (CH) 2010-01-28 US disclosed
US-7557135-B2 Inhibitors of cytosolic phospholipase A2 WYETH (US) 2009-07-07 US disclosed
EP-0416319-A2 Process for the preparation of sulfonylisoureas BAYER AG (DE) 1991-03-13 EP disclosed
EP-0372326-A2 Sulfonyl amino azines, processes for their preparation and their use as herbicides BAYER AG (DE) 1990-06-13 EP disclosed
US-4897105-A (1,2,4)-THIADIAZOLO(2,3-A)PYRIMIDINE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-01-30 US disclosed
US-4802910-A Herbicidal acylated sulphonylguanidines BAYER AKTIENGESELLSCHAFT (DE) 1989-02-07 US disclosed
US-4737185-A Herbicidal 2,6-disubstituted benzylsulfonamides and benzebesulfamates E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-04-12 US disclosed
CN-87102275-A Selective herbicide and manufacturing thereof and use 1988-02-17 CN disclosed
EP-0239064-A2 Herbicidal compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-09-30 EP disclosed
EP-0234250-A2 Acylated sulphonylguanidines BAYER AG (DE) 1987-09-02 EP disclosed
US-4678500-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-07-07 US disclosed
EP-0173321-A1 Sulfonyl-guanidinopyrimidine derivatives BAYER AG (DE) 1986-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A ALDH1A1 2405/4885LMNA 782/4885CA1 1223/4885
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A ALDH1A1 2405/4885LMNA 782/4885CA1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.